Finance

Lists
MRSH:BCBA
Marsh & Mclennan CEDEAR
ARS 19,330.00
+2.06%
(+390.00) 1D
Aug 28, 5:00:00 PM GMT-3  ·   ARS
All symbols
SymbolPriceChange% Change
Generating top insights for MRSH...
Open
ARS 19,360.00
High
ARS 19,460.00
Low
ARS 19,260.00
Mkt. cap
90.67B
Avg. vol.
624.00
Volume
298.00
52-wk high
ARS 19,710.00
52-wk low
ARS 14,590.00
Shares outstanding
477.21M
No. of employees
95K
Open
ARS 19,360.00
High
ARS 19,460.00
Low
ARS 19,260.00
Mkt. cap
90.67B
Avg. vol.
624.00
Volume
298.00
52-wk high
ARS 19,710.00
52-wk low
ARS 14,590.00
Shares outstanding
477.21M
No. of employees
95K
News stories
From web sources and news partners
Profile
Marsh & McLennan Companies, Inc., doing business as Marsh McLennan and Marsh, is an American professional services firm headquartered in New York City, with businesses in insurance brokerage, risk management, reinsurance services, talent management, investment advisory, and management consulting. Its four main operating companies are Marsh, which offers risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services; Marsh Re, a reinsurance intermediary and advisor; Mercer, which provides consulting to employers for health insurance, retirement plans, and pension plans; and Oliver Wyman, including Lippincott and NERA Economic Consulting, which provides consulting services. In 2024, risk and insurance services contributed a total of 63% of revenues and 71% of operating profit, while consulting contributed 37% of revenues and 29% of operating profit. It is the largest insurance broker worldwide. The company is ranked 175th on the Fortune 500 and 267th on the Forbes Global 2000. Wikipedia
About Marsh & Mclennan CEDEAR
CEOJohn Q. Doyle
Employees95K
Founded1905
HeadquartersNew York, New York, United States
SectorInsurance
Websitecorporate.marsh.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.35B
6.60B
7.60B
7.40B
Cost of goods sold
3.84B
3.78B
4.05B
4.09B
Cost of revenue
3.84B
3.78B
4.05B
4.09B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
1.29B
1.13B
1.70B
1.36B
Total operating expenses
5.13B
4.92B
5.75B
5.46B
Operating income
1.22B
1.68B
1.85B
1.95B
Other non operating income
-
-
-
-
EBT including unusual items
1.01B
1.06B
1.58B
1.70B
EBT excluding unusual items
1.01B
1.46B
1.63B
1.71B
Income tax expense
253.00M
222.00M
395.00M
411.00M
Effective tax rate
25.05%
21.02%
24.98%
24.15%
Other operating expenses
1.29B
1.13B
1.70B
1.36B
Net income
747.00M
821.00M
1.15B
1.27B
Net profit margin
11.76%
12.45%
15.08%
17.10%
Earnings per share
1.85
2.12
3.29
2.96
Interest and investment income
25.00M
21.00M
17.00M
8.00M
Interest expense
-237.00M
-235.00M
-240.00M
-250.00M
Net interest expenses
-212.00M
-214.00M
-223.00M
-242.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.45B
1.91B
2.08B
2.18B
Gain or loss from assets sale
-2.00M
4.00M
-
-7.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps